| Dr Tait D Fors, MD | |
|
1265 W American Dr Ste 100, Neenah, WI 54956 | |
| (920) 722-7747 | |
| Not Available |
| Full Name | Dr Tait D Fors |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 24 Years |
| Location | 1265 W American Dr Ste 100, Neenah, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649293358 | NPI | - | NPPES |
| 1649293358 | Medicaid | WI | |
| 49453-20 | Other | WI | STATE MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 49453 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thedacare Regional Medical Center - Appleton Inc | Appleton, WI | Hospital |
| Thedacare Regional Med Ctr - Neenah | Neenah, WI | Hospital |
| Thedacare Medical Center-waupaca | Waupaca, WI | Hospital |
| Thedacare Medical Center - New London | New london, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ascension Medical Group-fox Valley Wisconsin Inc | 0244142420 | 258 |
| Wisconsin Institute Of Urology Sc | 6608058078 | 18 |
News Archive
BG Medicine, Inc., a U.S. based, privately-held biomarker discovery and in vitro diagnostics company, announced today that there will be several data presentations regarding galectin-3 at the Heart Failure Congress 2010, the annual scientific meeting of the Heart Failure Association of the European Society of Cardiology, to be held in Berlin, Germany, on May 29th through June 1st. BG Medicine has developed and applied for FDA clearance of an in vitro diagnostic test to measure galectin-3 levels in plasma or serum.
The Renfrew Center, the country's leading authority on eating disorder treatment and research, recently announced the expansion of its services into Central America through a partnership with the Guatemala-based AKASA treatment center. The first center in Central America exclusively dedicated to the treatment of women with eating disorders, AKASA now operates as an independent affiliate of The Renfrew Center.
Stratasys Ltd., a leading global provider of 3D printing and additive manufacturing solutions, today announced that it has entered into definitive agreements to acquire two privately-held companies, Solid Concepts Inc. and Harvest Technologies.
The U.S. Food and Drug Administration today approved Admelog (insulin lispro injection), a short-acting insulin indicated to improve control in blood sugar levels in adults and pediatric patients aged 3 years and older with type 1 diabetes mellitus and adults with type 2 diabetes mellitus.
For some time, scientists have been tracking down the sequence of biochemical steps required to attract and assemble at the head end of a gene the molecular machinery needed to transcribe that gene to put to work the information it encodes.
› Verified 3 days ago
| Entity Name | Ascension Medical Group-fox Valley Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730126392 PECOS PAC ID: 0244142420 Enrollment ID: O20031105000351 |
News Archive
BG Medicine, Inc., a U.S. based, privately-held biomarker discovery and in vitro diagnostics company, announced today that there will be several data presentations regarding galectin-3 at the Heart Failure Congress 2010, the annual scientific meeting of the Heart Failure Association of the European Society of Cardiology, to be held in Berlin, Germany, on May 29th through June 1st. BG Medicine has developed and applied for FDA clearance of an in vitro diagnostic test to measure galectin-3 levels in plasma or serum.
The Renfrew Center, the country's leading authority on eating disorder treatment and research, recently announced the expansion of its services into Central America through a partnership with the Guatemala-based AKASA treatment center. The first center in Central America exclusively dedicated to the treatment of women with eating disorders, AKASA now operates as an independent affiliate of The Renfrew Center.
Stratasys Ltd., a leading global provider of 3D printing and additive manufacturing solutions, today announced that it has entered into definitive agreements to acquire two privately-held companies, Solid Concepts Inc. and Harvest Technologies.
The U.S. Food and Drug Administration today approved Admelog (insulin lispro injection), a short-acting insulin indicated to improve control in blood sugar levels in adults and pediatric patients aged 3 years and older with type 1 diabetes mellitus and adults with type 2 diabetes mellitus.
For some time, scientists have been tracking down the sequence of biochemical steps required to attract and assemble at the head end of a gene the molecular machinery needed to transcribe that gene to put to work the information it encodes.
› Verified 3 days ago
| Entity Name | Wisconsin Institute Of Urology Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578872628 PECOS PAC ID: 6608058078 Enrollment ID: O20110307000045 |
News Archive
BG Medicine, Inc., a U.S. based, privately-held biomarker discovery and in vitro diagnostics company, announced today that there will be several data presentations regarding galectin-3 at the Heart Failure Congress 2010, the annual scientific meeting of the Heart Failure Association of the European Society of Cardiology, to be held in Berlin, Germany, on May 29th through June 1st. BG Medicine has developed and applied for FDA clearance of an in vitro diagnostic test to measure galectin-3 levels in plasma or serum.
The Renfrew Center, the country's leading authority on eating disorder treatment and research, recently announced the expansion of its services into Central America through a partnership with the Guatemala-based AKASA treatment center. The first center in Central America exclusively dedicated to the treatment of women with eating disorders, AKASA now operates as an independent affiliate of The Renfrew Center.
Stratasys Ltd., a leading global provider of 3D printing and additive manufacturing solutions, today announced that it has entered into definitive agreements to acquire two privately-held companies, Solid Concepts Inc. and Harvest Technologies.
The U.S. Food and Drug Administration today approved Admelog (insulin lispro injection), a short-acting insulin indicated to improve control in blood sugar levels in adults and pediatric patients aged 3 years and older with type 1 diabetes mellitus and adults with type 2 diabetes mellitus.
For some time, scientists have been tracking down the sequence of biochemical steps required to attract and assemble at the head end of a gene the molecular machinery needed to transcribe that gene to put to work the information it encodes.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tait D Fors, MD 1265 W American Dr Ste 100, Neenah, WI 54956-1405 Ph: (920) 722-7747 | Dr Tait D Fors, MD 1265 W American Dr Ste 100, Neenah, WI 54956 Ph: (920) 722-7747 |
News Archive
BG Medicine, Inc., a U.S. based, privately-held biomarker discovery and in vitro diagnostics company, announced today that there will be several data presentations regarding galectin-3 at the Heart Failure Congress 2010, the annual scientific meeting of the Heart Failure Association of the European Society of Cardiology, to be held in Berlin, Germany, on May 29th through June 1st. BG Medicine has developed and applied for FDA clearance of an in vitro diagnostic test to measure galectin-3 levels in plasma or serum.
The Renfrew Center, the country's leading authority on eating disorder treatment and research, recently announced the expansion of its services into Central America through a partnership with the Guatemala-based AKASA treatment center. The first center in Central America exclusively dedicated to the treatment of women with eating disorders, AKASA now operates as an independent affiliate of The Renfrew Center.
Stratasys Ltd., a leading global provider of 3D printing and additive manufacturing solutions, today announced that it has entered into definitive agreements to acquire two privately-held companies, Solid Concepts Inc. and Harvest Technologies.
The U.S. Food and Drug Administration today approved Admelog (insulin lispro injection), a short-acting insulin indicated to improve control in blood sugar levels in adults and pediatric patients aged 3 years and older with type 1 diabetes mellitus and adults with type 2 diabetes mellitus.
For some time, scientists have been tracking down the sequence of biochemical steps required to attract and assemble at the head end of a gene the molecular machinery needed to transcribe that gene to put to work the information it encodes.
› Verified 3 days ago
Dr. Eric Jon Lawatsch, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1265 W American Dr Ste 100, Neenah, WI 54956 Phone: 920-722-7747 | |
Dr. Robert Elmer Vlach Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1265 W American Dr Ste 100, Neenah, WI 54956 Phone: 920-722-7747 | |
Dr. Omar Atassi, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1265 W American Dr Ste 100, Neenah, WI 54956 Phone: 920-722-7747 | |
Mr. Michael J Murphy, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1265 W American Dr Ste 100, Neenah, WI 54956 Phone: 920-722-7747 | |
Joshua K Modder, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1265 W American Dr Ste 100, Neenah, WI 54956 Phone: 920-722-7747 | |
John T Campbell, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 411 Lincoln St, Neenah, WI 54956 Phone: 920-727-4233 | |
Mr. Daniel J Higgins, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1265 W American Dr Ste 100, Neenah, WI 54956 Phone: 920-722-7747 |